Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Longevity | 21 | 2026 | 173 | 3.470 |
Why?
|
| Telomerase | 16 | 2016 | 42 | 3.210 |
Why?
|
| Telomere | 13 | 2021 | 59 | 2.970 |
Why?
|
| Polymorphism, Single Nucleotide | 19 | 2025 | 863 | 2.220 |
Why?
|
| Aging | 9 | 2026 | 783 | 1.700 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2016 | 88 | 1.200 |
Why?
|
| Germ Cells | 3 | 2016 | 74 | 0.980 |
Why?
|
| Hypertension | 8 | 2026 | 835 | 0.910 |
Why?
|
| Military Personnel | 2 | 2025 | 110 | 0.840 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2024 | 81 | 0.840 |
Why?
|
| Genotype | 13 | 2025 | 800 | 0.840 |
Why?
|
| Pluripotent Stem Cells | 2 | 2012 | 31 | 0.650 |
Why?
|
| Embryonic Stem Cells | 2 | 2011 | 55 | 0.650 |
Why?
|
| Cell Hypoxia | 3 | 2016 | 60 | 0.640 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2010 | 54 | 0.600 |
Why?
|
| Cardiovascular Diseases | 1 | 2026 | 749 | 0.590 |
Why?
|
| Hematopoietic Stem Cells | 5 | 2010 | 47 | 0.520 |
Why?
|
| Aged, 80 and over | 15 | 2026 | 2853 | 0.480 |
Why?
|
| Humans | 42 | 2026 | 43102 | 0.450 |
Why?
|
| Stem Cells | 1 | 2016 | 152 | 0.440 |
Why?
|
| Male | 29 | 2026 | 23409 | 0.420 |
Why?
|
| Dermatitis, Atopic | 2 | 2012 | 10 | 0.410 |
Why?
|
| Mice | 16 | 2023 | 6644 | 0.400 |
Why?
|
| Sapogenins | 1 | 2013 | 3 | 0.400 |
Why?
|
| Alleles | 7 | 2024 | 352 | 0.400 |
Why?
|
| Enzyme Activators | 1 | 2013 | 11 | 0.400 |
Why?
|
| Receptors, Somatotropin | 2 | 2024 | 18 | 0.390 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2013 | 15 | 0.390 |
Why?
|
| Dementia, Vascular | 2 | 2023 | 35 | 0.390 |
Why?
|
| Sirtuins | 3 | 2018 | 14 | 0.380 |
Why?
|
| Japan | 10 | 2024 | 348 | 0.380 |
Why?
|
| Aged | 17 | 2026 | 8214 | 0.370 |
Why?
|
| Coronary Artery Disease | 3 | 2024 | 163 | 0.340 |
Why?
|
| Cell Differentiation | 3 | 2016 | 638 | 0.320 |
Why?
|
| Animals | 20 | 2025 | 16992 | 0.320 |
Why?
|
| Tacrolimus | 1 | 2010 | 16 | 0.310 |
Why?
|
| DNA Damage | 2 | 2009 | 356 | 0.310 |
Why?
|
| Lung | 1 | 2013 | 492 | 0.310 |
Why?
|
| Immunosuppressive Agents | 2 | 2010 | 94 | 0.310 |
Why?
|
| RNA Interference | 1 | 2010 | 247 | 0.300 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 161 | 0.270 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 1070 | 0.270 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 592 | 0.260 |
Why?
|
| Spermatogenesis | 1 | 2008 | 161 | 0.250 |
Why?
|
| Chorionic Villi | 1 | 2006 | 5 | 0.250 |
Why?
|
| Australia | 1 | 2026 | 103 | 0.240 |
Why?
|
| Cohort Studies | 3 | 2026 | 1759 | 0.240 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 1001 | 0.220 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2025 | 18 | 0.220 |
Why?
|
| Valine | 1 | 2024 | 29 | 0.220 |
Why?
|
| Female | 16 | 2024 | 24698 | 0.220 |
Why?
|
| Amino Acid Substitution | 1 | 2024 | 135 | 0.210 |
Why?
|
| Sirtuin 1 | 3 | 2016 | 34 | 0.210 |
Why?
|
| Geriatrics | 1 | 2025 | 67 | 0.210 |
Why?
|
| Athletes | 1 | 2025 | 62 | 0.210 |
Why?
|
| Phenylbutyrates | 1 | 2023 | 5 | 0.210 |
Why?
|
| Flavonols | 1 | 2023 | 19 | 0.210 |
Why?
|
| Risk Factors | 9 | 2024 | 3994 | 0.210 |
Why?
|
| Mice, Knockout | 5 | 2009 | 1035 | 0.200 |
Why?
|
| Brain | 3 | 2023 | 1472 | 0.200 |
Why?
|
| Oxidative Stress | 1 | 2009 | 1003 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 213 | 0.190 |
Why?
|
| Hydrogen Sulfide | 1 | 2023 | 77 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 1869 | 0.190 |
Why?
|
| Young Adult | 4 | 2025 | 5080 | 0.180 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 80 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2024 | 760 | 0.180 |
Why?
|
| Testis | 2 | 2016 | 207 | 0.170 |
Why?
|
| Cerebral Hemorrhage | 1 | 2022 | 104 | 0.170 |
Why?
|
| Heart Diseases | 1 | 2022 | 112 | 0.170 |
Why?
|
| Middle Aged | 7 | 2026 | 12222 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2021 | 430 | 0.170 |
Why?
|
| Diabetes Mellitus | 1 | 2026 | 539 | 0.160 |
Why?
|
| Leukocytes | 2 | 2018 | 80 | 0.160 |
Why?
|
| Antioxidants | 1 | 2023 | 443 | 0.160 |
Why?
|
| T-Lymphocytes | 1 | 2002 | 386 | 0.160 |
Why?
|
| Coronary Disease | 1 | 2020 | 123 | 0.160 |
Why?
|
| Carrier Proteins | 2 | 2014 | 321 | 0.150 |
Why?
|
| Adult | 6 | 2025 | 13872 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2024 | 609 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 495 | 0.150 |
Why?
|
| Xanthophylls | 3 | 2023 | 21 | 0.140 |
Why?
|
| Stress, Psychological | 1 | 2024 | 661 | 0.140 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2017 | 19 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2017 | 20 | 0.130 |
Why?
|
| Neuroprotective Agents | 1 | 2020 | 269 | 0.130 |
Why?
|
| RNA | 2 | 2012 | 266 | 0.130 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2016 | 6 | 0.130 |
Why?
|
| Case-Control Studies | 5 | 2020 | 1285 | 0.130 |
Why?
|
| Sirtuin 3 | 1 | 2016 | 6 | 0.130 |
Why?
|
| Enzyme Activation | 2 | 2012 | 462 | 0.130 |
Why?
|
| Brain Ischemia | 1 | 2018 | 189 | 0.130 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 1063 | 0.130 |
Why?
|
| Prospective Studies | 4 | 2023 | 1600 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2009 | 346 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 196 | 0.120 |
Why?
|
| Pre-Eclampsia | 1 | 2016 | 67 | 0.120 |
Why?
|
| Encephalitis | 1 | 2016 | 43 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2024 | 734 | 0.120 |
Why?
|
| Ovum | 1 | 2016 | 63 | 0.120 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 423 | 0.120 |
Why?
|
| Ovary | 1 | 2016 | 113 | 0.120 |
Why?
|
| DNA-Binding Proteins | 3 | 2003 | 561 | 0.110 |
Why?
|
| Cause of Death | 1 | 2016 | 186 | 0.110 |
Why?
|
| Transfection | 1 | 2016 | 532 | 0.110 |
Why?
|
| Blotting, Southern | 2 | 2006 | 68 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 652 | 0.110 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 118 | 0.110 |
Why?
|
| Mortality | 1 | 2016 | 175 | 0.110 |
Why?
|
| Spermatozoa | 1 | 2016 | 214 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2014 | 23 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2006 | 665 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2016 | 883 | 0.100 |
Why?
|
| Monocytes | 1 | 2016 | 277 | 0.100 |
Why?
|
| Neoplasms | 1 | 2005 | 1377 | 0.100 |
Why?
|
| Bone Marrow Cells | 2 | 2010 | 79 | 0.100 |
Why?
|
| Base Sequence | 2 | 2017 | 983 | 0.100 |
Why?
|
| Bleomycin | 1 | 2013 | 20 | 0.100 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 41 | 0.100 |
Why?
|
| Hawaii | 4 | 2024 | 2011 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 760 | 0.090 |
Why?
|
| International Cooperation | 1 | 2012 | 52 | 0.090 |
Why?
|
| Collagen | 1 | 2013 | 181 | 0.090 |
Why?
|
| Overweight | 1 | 2014 | 249 | 0.090 |
Why?
|
| Gestational Age | 2 | 2016 | 200 | 0.090 |
Why?
|
| Gene Frequency | 3 | 2018 | 206 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2013 | 281 | 0.090 |
Why?
|
| Heterozygote | 3 | 2018 | 110 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 719 | 0.080 |
Why?
|
| Phenotype | 3 | 2020 | 780 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2011 | 63 | 0.080 |
Why?
|
| Incidence | 2 | 2024 | 1078 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2012 | 259 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2016 | 460 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 189 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinase 5 | 2 | 2021 | 13 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1124 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 1596 | 0.080 |
Why?
|
| Nicotinic Agonists | 1 | 2010 | 88 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 153 | 0.080 |
Why?
|
| Cell Line | 2 | 2010 | 1410 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2010 | 317 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2012 | 1604 | 0.070 |
Why?
|
| Homeostasis | 1 | 2010 | 192 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2018 | 2157 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 526 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2009 | 58 | 0.070 |
Why?
|
| Oogenesis | 1 | 2008 | 29 | 0.070 |
Why?
|
| Multienzyme Complexes | 1 | 2008 | 69 | 0.070 |
Why?
|
| Haplotypes | 2 | 2018 | 197 | 0.070 |
Why?
|
| Inflammation | 1 | 2013 | 758 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 1542 | 0.070 |
Why?
|
| Nicotine | 1 | 2010 | 302 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2011 | 1455 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2012 | 735 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2006 | 30 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2006 | 150 | 0.060 |
Why?
|
| Cell Count | 1 | 2006 | 145 | 0.060 |
Why?
|
| Fetal Blood | 1 | 2006 | 48 | 0.060 |
Why?
|
| Graft Survival | 2 | 2003 | 47 | 0.060 |
Why?
|
| Time Factors | 2 | 2010 | 1857 | 0.060 |
Why?
|
| Models, Biological | 1 | 2009 | 712 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2010 | 1546 | 0.060 |
Why?
|
| Age Factors | 2 | 2020 | 1154 | 0.060 |
Why?
|
| Mutation | 1 | 2009 | 1177 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2006 | 456 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 300 | 0.050 |
Why?
|
| Movement | 1 | 2025 | 119 | 0.050 |
Why?
|
| Meclizine | 1 | 2023 | 2 | 0.050 |
Why?
|
| Cell Survival | 2 | 2008 | 945 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 704 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2023 | 16 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 143 | 0.050 |
Why?
|
| Smoking | 1 | 2010 | 1024 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2023 | 63 | 0.050 |
Why?
|
| DNA | 1 | 2006 | 592 | 0.050 |
Why?
|
| Telomeric Repeat Binding Protein 1 | 1 | 2002 | 5 | 0.050 |
Why?
|
| Asia | 1 | 2023 | 98 | 0.050 |
Why?
|
| Transgenes | 1 | 2003 | 65 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 311 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2002 | 2 | 0.050 |
Why?
|
| Life Style | 1 | 2024 | 334 | 0.050 |
Why?
|
| DNA Replication | 1 | 2003 | 148 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 3156 | 0.050 |
Why?
|
| Cell Death | 1 | 2003 | 278 | 0.050 |
Why?
|
| Integrins | 1 | 2002 | 54 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 249 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 187 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 1067 | 0.040 |
Why?
|
| Child | 1 | 2010 | 3443 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2022 | 138 | 0.040 |
Why?
|
| Educational Status | 1 | 2023 | 339 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2021 | 139 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 368 | 0.040 |
Why?
|
| Gene Expression | 1 | 2003 | 701 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2021 | 389 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 21 | 0.040 |
Why?
|
| Linkage Disequilibrium | 1 | 2018 | 86 | 0.040 |
Why?
|
| Independent Living | 1 | 2018 | 47 | 0.040 |
Why?
|
| Hydra | 1 | 2018 | 4 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2024 | 518 | 0.030 |
Why?
|
| Cell Movement | 1 | 2002 | 655 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 355 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2017 | 561 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 863 | 0.030 |
Why?
|
| Laminin | 1 | 2017 | 58 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2017 | 57 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 11 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2021 | 925 | 0.030 |
Why?
|
| Trophoblasts | 1 | 2016 | 33 | 0.030 |
Why?
|
| Genome, Human | 1 | 2017 | 144 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 91 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2016 | 53 | 0.030 |
Why?
|
| United States | 2 | 2017 | 5205 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1612 | 0.030 |
Why?
|
| Chromatin | 1 | 2017 | 186 | 0.030 |
Why?
|
| Placenta | 1 | 2016 | 117 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 671 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 209 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 587 | 0.030 |
Why?
|
| Cognition | 1 | 2018 | 473 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 638 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 173 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 384 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1082 | 0.030 |
Why?
|
| Cytokines | 1 | 2016 | 678 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1271 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 1772 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2010 | 8 | 0.020 |
Why?
|
| Bungarotoxins | 1 | 2010 | 21 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 19 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2010 | 9 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 69 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2010 | 104 | 0.020 |
Why?
|
| Spleen | 1 | 2010 | 204 | 0.020 |
Why?
|
| Saccharomycetales | 1 | 2009 | 8 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 260 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 2010 | 114 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2008 | 68 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2010 | 386 | 0.020 |
Why?
|
| Quality of Life | 1 | 2012 | 616 | 0.020 |
Why?
|
| Food | 1 | 2008 | 103 | 0.020 |
Why?
|
| Glucose | 1 | 2008 | 244 | 0.020 |
Why?
|
| Antigens, Ly | 1 | 2002 | 8 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2002 | 14 | 0.010 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2002 | 18 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2002 | 59 | 0.010 |
Why?
|
| Apoptosis | 1 | 2009 | 1568 | 0.010 |
Why?
|